Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000133

Chief Financial Officer sold 2,179 shares at $24.79 ($54,017)

  • Chief Financial Officer acquired 7,472 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jones Cecilia · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-26 Exercise or conversion : show line 1 in the form 10b5-1 +7,472 11,754 D
2023-09-28 Sale : show line 2 in the form 10b5-1 −2,179 $24.79 $54,017 9,575 D
Open-market sales · 2,179 sh · avg $24.79 · $54,017

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-26 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −7,472 14,945 D
Loading xslF345X05/wk-form4_1695931360.xml…